SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021953
Filing Date
2020-05-06
Accepted
2020-05-06 16:20:51
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20200331.htm 10-Q 2102459
2 EX-31.1 cnst-ex311_7.htm EX-31.1 9602
3 EX-31.2 cnst-ex312_8.htm EX-31.2 9575
4 EX-32.1 cnst-ex321_9.htm EX-32.1 5670
5 EX-32.2 cnst-ex322_6.htm EX-32.2 5750
  Complete submission text file 0001564590-20-021953.txt   6585846

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnst-20200331.xml EX-101.INS 1477888
7 XBRL TAXONOMY EXTENSION SCHEMA cnst-20200331.xsd EX-101.SCH 41358
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20200331_cal.xml EX-101.CAL 38139
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20200331_def.xml EX-101.DEF 112385
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20200331_lab.xml EX-101.LAB 321270
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20200331_pre.xml EX-101.PRE 240937
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 20852900
SIC: 2834 Pharmaceutical Preparations